FDA guidance would cut back on using monkeys for safety testing of monoclonal antibodies
Regulatory NewsEmily Hayes
Biologics/ biosimilars/ vaccinesGuidancePreclinical studyProduct LifecycleUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsEmily HayesBiologics/ biosimilars/ vaccinesGuidancePreclinical studyProduct LifecycleUnited StatesUS Food and Drug Administration (FDA)